Leadership Overview
Cipla has 10 executives leading key functions including North American strategy, digital health, information technology, financial oversight, commercial excellence, operational support, revenue growth, marketing operations, human capital, and brand marketing.
Focused on delivering affordable healthcare solutions globally, Cipla maintains a commitment to improving patient access through innovation in respiratory, cardiovascular, and infectious disease treatments across diverse international markets.
Focused on delivering affordable healthcare solutions globally, Cipla maintains a commitment to improving patient access through innovation in respiratory, cardiovascular, and infectious disease treatments across diverse international markets.
Leadership Roles at Cipla
Marc Falkin - Chief Executive Officer (North America)
Marc Falkin, the Chief Executive Officer (North America) at Cipla, directs all strategic initiatives across the United States and surrounding regional markets. Falkin oversees the expansion of the generic and branded generic medicine portfolio, ensuring alignment with complex regulatory requirements and competitive market dynamics. By managing relationships with key healthcare stakeholders, the Chief Executive Officer (North America) drives revenue growth and strengthens the company's footprint in the North American pharmaceutical sector. This leadership role involves optimizing supply chain logistics to ensure consistent product availability for critical therapeutic areas like respiratory and cardiovascular care. Marc Falkin prioritizes operational efficiency to maintain high standards of quality and compliance. Through rigorous market analysis and strategic planning, the Chief Executive Officer (North America) secures long-term stability and growth for the organization within this vital geographic territory.
Ashish Vig - Chief Executive Officer, Cipla Digital Health & Leader (eCommerce, Modern Trade, Organized Retail Pharmacies)
Ashish Vig, the Chief Executive Officer, Cipla Digital Health & Leader (eCommerce, Modern Trade, Organized Retail Pharmacies) at Cipla, architects the digital transformation of consumer healthcare distribution. Vig manages the integration of modern trade channels and organized retail pharmacy partnerships to enhance product accessibility. By leveraging eCommerce platforms, the Chief Executive Officer, Cipla Digital Health & Leader (eCommerce, Modern Trade, Organized Retail Pharmacies) expands the reach of branded generic medicines and consumer health products. This role involves coordinating with technology teams to streamline digital customer experiences and optimize inventory management across diverse retail networks. Ashish Vig drives innovation in digital health services, ensuring the company remains at the forefront of modern pharmaceutical retail. Through strategic digital initiatives, the Chief Executive Officer, Cipla Digital Health & Leader (eCommerce, Modern Trade, Organized Retail Pharmacies) maximizes market penetration and improves overall consumer engagement with the brand.
Satish Kadam - Chief Financial Officer
Satish Kadam, the Chief Financial Officer at Cipla, manages the global financial health and capital allocation strategies for the organization. Kadam oversees fiscal planning, budgeting, and investment decisions that support the development of new pharmaceutical ventures and biosimilars. By monitoring financial performance across India, South Africa, and other international markets, the Chief Financial Officer ensures the company maintains a strong balance sheet to fund ongoing research in oncology and respiratory care. This leadership role involves coordinating with the Board to provide transparent financial reporting and risk management strategies. Satish Kadam drives cost-optimization initiatives across manufacturing and distribution segments to improve profit margins. Through rigorous financial oversight, the Chief Financial Officer secures the necessary resources to sustain long-term growth and innovation, ensuring the company remains a competitive player in the global healthcare industry while delivering consistent value to stakeholders.
Vishrut Awasthi - Commercial Excellence Lead - Global Chief Operating Officer Office
Vishrut Awasthi, the Commercial Excellence Lead - Global Chief Operating Officer Office at Cipla, directs the optimization of sales processes and market entry strategies. Awasthi oversees the alignment of commercial activities with global operational goals, ensuring that finished formulations reach target markets efficiently. By analyzing market trends and performance metrics, the Commercial Excellence Lead - Global Chief Operating Officer Office identifies opportunities to improve the distribution of medicines for chronic conditions like diabetes and psychiatric disorders. This role involves collaborating with regional teams to standardize sales practices and enhance customer relationship management. Vishrut Awasthi drives initiatives that increase the effectiveness of the global sales force, supporting the company's broader mission of expanding access to affordable healthcare. Through data-driven commercial strategies, the Commercial Excellence Lead - Global Chief Operating Officer Office ensures that operational resources are deployed effectively to maximize market share and support sustainable revenue growth.
Shardul Parab - Team Member - Global Chief Operating Officer Office
Shardul Parab, the Team Member - Global Chief Operating Officer Office at Cipla, supports the execution of operational strategies across the company's diverse manufacturing and distribution network. Parab assists in coordinating cross-functional projects that streamline the production of active pharmaceutical ingredients and finished formulations. By monitoring operational workflows, the Team Member - Global Chief Operating Officer Office ensures that internal processes remain aligned with global quality standards and efficiency targets. This role involves facilitating communication between regional operations and the central office to resolve logistical challenges in the supply chain. Shardul Parab drives continuous improvement initiatives that enhance the manufacturing output for critical care and women’s health products. Through meticulous project management and operational support, the Team Member - Global Chief Operating Officer Office contributes to the overall stability and performance of the company's global healthcare operations, ensuring that strategic objectives are met with precision and consistency.
Sneha Hiranandani - Chief Information Officer
Sneha Hiranandani, the Chief Information Officer at Cipla, directs the global technology infrastructure supporting pharmaceutical manufacturing and distribution. Hiranandani oversees the implementation of secure data systems that protect sensitive research and patient information across international operations. By modernizing enterprise resource planning tools, the Chief Information Officer ensures seamless communication between global manufacturing sites and regional distribution hubs. This leadership role involves managing cybersecurity protocols to safeguard intellectual property and maintain compliance with global data privacy standards. Sneha Hiranandani drives digital efficiency by integrating advanced analytics into the supply chain, allowing for real-time monitoring of finished formulations and active pharmaceutical ingredients. Through the deployment of scalable cloud solutions, the Chief Information Officer supports the company's mission to provide high-quality medicines through robust, technology-driven processes that enhance operational agility and data-backed decision-making across the entire global organization.
Kanchan Israni - Chief Revenue Officer, Category Lead Outsourcing
Kanchan Israni, the Chief Revenue Officer, Category Lead Outsourcing at Cipla, directs revenue generation strategies and manages external partnerships for pharmaceutical outsourcing. Israni oversees the identification and development of new business opportunities within the global market, focusing on expanding the reach of the company's diverse therapeutic portfolio. By managing outsourcing categories, the Chief Revenue Officer, Category Lead Outsourcing ensures that manufacturing and distribution partnerships align with the company's quality and cost-efficiency standards. This leadership role involves negotiating contracts and fostering long-term relationships with key industry partners to support the production of vaccines and specialty medicines. Kanchan Israni drives revenue growth by optimizing the product mix and identifying high-potential market segments. Through strategic oversight of outsourcing operations, the Chief Revenue Officer, Category Lead Outsourcing ensures that the company maintains a competitive edge while delivering essential healthcare solutions to patients worldwide.
Rohidas Patil - Sr. Executive Chief Marketing Officer Operations
Rohidas Patil, the Sr. Executive Chief Marketing Officer Operations at Cipla, directs the operational framework for global marketing campaigns and brand positioning. Patil oversees the execution of promotional strategies for branded generic medicines, ensuring consistent messaging across diverse international markets. By managing marketing operations, the Sr. Executive Chief Marketing Officer Operations coordinates the launch of new products in therapeutic areas such as ophthalmology and infectious diseases. This role involves aligning marketing activities with sales objectives to drive brand awareness and market penetration. Rohidas Patil drives the implementation of marketing technology tools to track campaign performance and optimize resource allocation. Through the management of complex marketing workflows, the Sr. Executive Chief Marketing Officer Operations ensures that the company's brand remains strong and recognizable, supporting the overall mission of providing accessible healthcare solutions to patients and healthcare providers globally.
Sanjivani Sadani - Chief People Officer
Sanjivani Sadani, the Chief People Officer at Cipla, directs the human capital strategy and organizational development initiatives. Sadani oversees talent acquisition, employee engagement, and leadership development programs that support the company's global workforce. By fostering a culture of innovation and excellence, the Chief People Officer ensures that the organization attracts and retains top talent in the pharmaceutical and biotechnology sectors. This leadership role involves designing performance management systems that align individual contributions with the company's mission of improving patient health. Sanjivani Sadani drives diversity and inclusion efforts to build a collaborative environment across international operations. Through the implementation of comprehensive training and development programs, the Chief People Officer empowers employees to contribute effectively to the company's growth. By prioritizing the well-being and professional growth of the workforce, the Chief People Officer ensures that the organization remains a leader in the global healthcare industry.
Gautam Jain - Markrting
Gautam Jain, the Markrting at Cipla, directs the development and execution of targeted marketing strategies for the company's pharmaceutical portfolio. Jain oversees the creation of promotional materials and educational content for healthcare professionals, focusing on therapeutic areas like respiratory and asthma care. By analyzing market data, the Markrting identifies emerging trends and adjusts promotional tactics to maintain a competitive advantage. This role involves collaborating with cross-functional teams to ensure that marketing initiatives support the launch of new formulations and specialty medicines. Gautam Jain drives brand visibility through strategic communication and engagement programs that highlight the efficacy and accessibility of the company's products. Through the management of marketing campaigns, the Markrting ensures that the company's value proposition is clearly communicated to stakeholders, ultimately supporting the mission of improving patient outcomes through high-quality, affordable healthcare solutions across diverse global markets.
Explore Leadership Teams in Manufacturing
Biogen is a U.S.-based biotechnology company focused on discovering, developing, and commercializing therapies for serious neurological and neurodegenerative diseases. Its core portfolio includes treatments for conditions such as multiple sclerosis, spinal muscular atrophy, and other rare neurological disorders, supported by advanced research in neuroscience, biologics, and gene-based therapies.
Company Leadership

DQ
WC
Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacturing, and commercialization of novel botulinum toxin products for various aesthetic and therapeutic indications. The company's lead drug candidate is DaxibotulinumtoxinA for injection (RT002), which is in Phase III clinical trials to treat glabellar (frown) lines, as well as in Phase II clinical trials for the treatment of cervical dystonia and plantar fasciitis. It is also developing DaxibotulinumtoxinA topical gel (RT001) that is in preclinical development. The company was formerly known as Essentia Biosystems, Inc. and changed its name to Revance Therapeutics, Inc. in April 2005. Revance Therapeutics, Inc. was founded in 1999 and is headquartered in Newark,...
Company Leadership
SK
MA
Founded in 1967, Douglas Pharmaceuticals is a manufacturer of pharmaceutical products. The company started out distributing prescription medicines, before manufacturing and later successfully researching and developing its products for export. The company is headquartered in Auckland, New Zealand.
Company Leadership SW
AM
TB
BL
EVA Pharma is a leading player in the Egyptian pharmaceutical industry, dedicated to innovating healthcare solutions that enhance the quality of life. With over 300 products in its portfolio and a robust pipeline of 500 products, the company focuses on addressing unmet medical needs across various therapeutic areas including oncology, neuroscience, and cardiometabolic medicine. EVA Pharma operates three internationally accredited manufacturing facilities and has a strong commitment to partnerships that facilitate access to life-saving treatments in low- to middle-income countries. With a century of expertise, the company emphasizes research and development as a core aspect of its operations.
Company Leadership
BM
EG
KN